Skip to main content
Back to News
Introducing GPT-Rosalind for life sciences research
Product
1 min read
US

Introducing GPT-Rosalind for life sciences research

The AMW Read

Updates the player map for Segment 06 by introducing a major frontier lab (OpenAI) into the vertical life sciences research space with a specialized model.
NoveltySignificance
Healthcare & Bio Β· Player Map
OpenAI
OpenAI

Foundation Models / LLMs

View Company Profile

Introducing GPT-Rosalind for life sciences research

OpenAI has introduced GPT-Rosalind, a new AI model designed to accelerate research in drug discovery, genomics, and protein analysis.

Original source: https://openai.com/index/introducing-gpt-rosalind/

#AI#life sciences#drug discovery#OpenAI

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 3d agoCuspAI raises $450M at $2.6B valuation for AI materials discovery, enlists Nvidia, Meta, Samsung in foundry coalitionCuspAI
  2. 3d agoColossal Biosciences seeks funding at $20-30B valuation for AI-driven de-extinction technologyColossal Biosciences
  3. 3d agoCuspAI raises $450M Series B at $2.6B valuation for AI-driven materials discoveryCuspAI
  4. 3w agoAnthropic launches Claude Science AI workbench for life sciences researchAnthropic
  5. 3mo agoIntroducing GPT-Rosalind for life sciences research Β· THIS ARTICLE

Related News

More news from OpenAI

Stay updated with the latest news and announcements from OpenAI.

View all OpenAI news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard